Table 1. Whole genome amplification and qPCR assay summary statistics.

Summary of the number and percentage of positive schistosome samples, the number of patients from which schistosome positive WGA were obtained, the average number of spots tested per patients in order to get at least one positive for schistosome, and the average (+ sd) DNA concentration recovered after WGA in ng. μL⁻¹ in 130 μL of sample.

Schistosome spp.	Location	Country	Collection date	No. schistosome positive WGA/Total no. WGA performed	% schistosome positive samples by qPCR	No. of patients with schistosome positive WGA/no. of patients	Average no. of spots tested per patient*	Average (+ sd) DNA conc. after WGA (ng.μL−1)**
S. mansoni	E. Africa	Tanzania	2012	60/101	59.40%	60/64	1.68	34 ± 5.19
	W. Africa	Senegal	2007–8	24/48	50%	23/27	2.09	28.74 ± 5.08
		Niger	2006–7	13/28	46.42%	13/17	2.23	24.63 ± 5.04
		Cameroon	2007	0/14	0%	0/6	-	-
S. haematobium	E. Africa	Zanzibar	2011	65/138	47.10%	62/80	2.22	22.45 ± 4.65
	W. Africa	Niger	2013	55/83	66.26%	52/57	1.60	21.21± 2.85

^*We initially conducted WGA from a single miracidia per patient: further WGA were done only if the initial sample was schistosome negative by qPCR

^**Only shown for schistosome positive samples